JPRN-UMIN000005349招募中未知
The evaluation of the efficacy of sitagliptin for NASH/NAFLD patients-a multicenter open-label study- - The treatment with sitagliptin for NASH/NAFLD
Kyoto Prefectural University of Medicine, Department of Gastroenterology and Hepatology0 个研究点目标入组 50 人开始时间: 2011年3月30日最近更新:
试验速览
- 阶段
- 未知
- 状态
- 招募中
- 发起方
- 入组人数
- 50
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 75years-old（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •1) drinkers (ethanol intake > 20g/day) 2) HBsAg and/or HCV Ab positive patients
研究者
相似试验
招募中
3 期
Evaluation of the effectiveness of sitagliptin on metabolic factors and liver enzymesIRCT20191209045671N2Semnan University of Medical Sciences60
招募中
2 期
?Evaluation the effects of Sitagliptin administration in patients with COVID-19Pneumonia of COVID-19.COVID-19, virus identifiedU07.1IRCT20200420047147N1Shahid Beheshti University of Medical Sciences84
尚未招募
4 期
A clinical study to understand the combined effects ofSitagliptin & metformin, in comparison to Glimepiride & metformin treatment in type 2 diabetes patientsCTRI/2024/04/065877Dr Keerthi Rajan M
已完成
2 期
Sitagliptin and Pioglitazon effects in the treatment of diabetesIRCT2015061619554N4Vice chancellor for research; Zanjan University of Medical Sciences160
已完成
不适用
Evaluation of the efficacy of Sitagliptin plus peginterferon alfa 2b /ribavirin combination therapy in CHC patients with insulin resistanceHepatitis CJPRN-UMIN000003957Hyogo College Of Medicine60